These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
168 related items for PubMed ID: 16218051
1. Endocrine and neuropsychological assessment in a child with a novel mutation of thyroid hormone receptor: response to 12-month triiodothyroacetic acid (TRIAC) therapy. Torre P, Bertoli M, Di Giovanni S, Scommegna S, Conte C, Novelli G, Cianfarani S. J Endocrinol Invest; 2005; 28(7):657-62. PubMed ID: 16218051 [Abstract] [Full Text] [Related]
2. Clinical and hormonal outcome after two years of triiodothyroacetic acid treatment in a child with thyroid hormone resistance. Radetti G, Persani L, Molinaro G, Mannavola D, Cortelazzi D, Chatterjee VK, Beck-Peccoz P. Thyroid; 1997 Oct; 7(5):775-8. PubMed ID: 9349583 [Abstract] [Full Text] [Related]
3. Long-term 3,5,3'-triiodothyroacetic acid therapy in a child with hyperthyroidism caused by thyroid hormone resistance: pharmacological study and therapeutic recommendations. Anzai R, Adachi M, Sho N, Muroya K, Asakura Y, Onigata K. Thyroid; 2012 Oct; 22(10):1069-75. PubMed ID: 22947347 [Abstract] [Full Text] [Related]
5. Therapeutic applications of thyroid hormone analogues in resistance to thyroid hormone (RTH) syndromes. Groeneweg S, Peeters RP, Visser TJ, Visser WE. Mol Cell Endocrinol; 2017 Dec 15; 458():82-90. PubMed ID: 28235578 [Abstract] [Full Text] [Related]
6. In vitro effect of Triac on resistance to thyroid hormone receptor mutants: potential basis for therapy. Messier N, Laflamme L, Hamann G, Langlois MF. Mol Cell Endocrinol; 2001 Mar 28; 174(1-2):59-69. PubMed ID: 11306172 [Abstract] [Full Text] [Related]
7. Successful therapy with 3,5,3'-triiodothyroacetic acid (TRIAC) in pituitary resistance to thyroid hormone. Darendeliler F, Baş F. J Pediatr Endocrinol Metab; 1997 Mar 28; 10(5):535-8. PubMed ID: 9401912 [No Abstract] [Full Text] [Related]
8. 9 years follow-up of a patient with pituitary form of resistance to thyroid hormones (PRTH): comparison of two treatment periods of D-thyroxine and triiodothyroacetic acid (TRIAC). Guran T, Turan S, Bircan R, Bereket A. J Pediatr Endocrinol Metab; 2009 Oct 28; 22(10):971-8. PubMed ID: 20020587 [Abstract] [Full Text] [Related]
9. Differences in response of thyrotropin to 3,5,3'-triiodothyronine and 3,5,3'-triiodothyroacetic acid in patients with resistance to thyroid hormone. Ueda S, Takamatsu J, Fukata S, Tanaka K, Shimizu N, Sakata S, Yamaji T, Kuma K, Ohsawa N. Thyroid; 1996 Dec 28; 6(6):563-70. PubMed ID: 9001190 [Abstract] [Full Text] [Related]
10. Detection of a new de novo mutation at codon 251 of exon 8 of thyroid hormone receptor beta gene in an Italian kindred with resistance to thyroid hormone. Macchia E, Agostini M, Sarkissian G, Giorgilli G, Canale D, Scartabelli G, Margotat A, Torresani J, Pinchera A. J Endocrinol Invest; 1998 Apr 28; 21(4):226-33. PubMed ID: 9624596 [Abstract] [Full Text] [Related]
11. A Rare Mutation in Patients With Resistance to Thyroid Hormone and Review of Therapeutic Strategies. Lai S, Zhang S, Wang L, Chen Z, Fu X, Jianhao P, Chen H, Kuang J. Am J Med Sci; 2015 Sep 28; 350(3):167-74. PubMed ID: 26273722 [Abstract] [Full Text] [Related]
12. Triiodothyroacetic acid has unique potential for therapy of resistance to thyroid hormone. Takeda T, Suzuki S, Liu RT, DeGroot LJ. J Clin Endocrinol Metab; 1995 Jul 28; 80(7):2033-40. PubMed ID: 7608251 [Abstract] [Full Text] [Related]
13. Diabetes mellitus in a girl with thyroid hormone resistance syndrome: a little recognized interaction between the two diseases. Stagi S, Manoni C, Cirello V, Covelli D, Giglio S, Chiarelli F, Seminara S, de Martino M. Hormones (Athens); 2014 Jul 28; 13(4):561-7. PubMed ID: 25402385 [Abstract] [Full Text] [Related]
14. Effective TRIAC treatment of a THRβ-mutated patient with thyroid hormone resistance. Carbone A, Verrienti A, Cito DS, Sponziello M, Pecce V, Bruno R. Endocrine; 2024 Aug 28; 85(2):598-600. PubMed ID: 38558372 [Abstract] [Full Text] [Related]
15. Triac regulation of transcription is T(3) receptor isoform- and response element-specific. Messier N, Langlois MF. Mol Cell Endocrinol; 2000 Jul 25; 165(1-2):57-66. PubMed ID: 10940484 [Abstract] [Full Text] [Related]
16. Resistance to thyroid hormone in a Chinese family with R429Q mutation in the thyroid hormone receptor beta gene. Kong AP, Lam CW, Chan AO, Yiu SF, Tiu SC. Hong Kong Med J; 2005 Apr 25; 11(2):125-9. PubMed ID: 15815068 [Abstract] [Full Text] [Related]
17. A novel 1297-1304delGCCTGCCA mutation in the exon 10 of the thyroid hormone receptor beta gene causes resistance to thyroid hormone. Rivolta CM, Mallea Gil MS, Ballarino C, Ridruejo MC, Miguel CM, Gimenez SB, Bernacchi SS, Targovnik HM. Mol Diagn; 2004 Apr 25; 8(3):163-9. PubMed ID: 15771554 [Abstract] [Full Text] [Related]
18. Retarded bone growth in thyroid hormone resistance. A clinical study of a large family with a novel thyroid hormone receptor mutation. Kvistad PH, Løvås K, Boman H, Myking OL. Eur J Endocrinol; 2004 Apr 25; 150(4):425-30. PubMed ID: 15080770 [Abstract] [Full Text] [Related]
19. A novel mutation (M310L) in the thyroid hormone receptor beta causing resistance to thyroid hormone in a Brazilian kindred and a neonate. Furlanetto TW, Kopp P, Peccin S, Gu WX, Jameson JL. Mol Genet Metab; 2000 Nov 25; 71(3):520-6. PubMed ID: 11073720 [Abstract] [Full Text] [Related]
20. Five new families with resistance to thyroid hormone not caused by mutations in the thyroid hormone receptor beta gene. Pohlenz J, Weiss RE, Macchia PE, Pannain S, Lau IT, Ho H, Refetoff S. J Clin Endocrinol Metab; 1999 Nov 25; 84(11):3919-28. PubMed ID: 10566629 [Abstract] [Full Text] [Related] Page: [Next] [New Search]